Aristolochic acid-induced carcinogenesis examined by ACB-PCR quantification of H-Ras and K-Ras mutant fraction

ACB-PCR Quantification of K-RASCodon 12 GAT and GTT Mutant Fraction in Colon Tumor and Non-Tumor Tissue

(2010) Barbara L. Parsons et al.   CANCER INVESTIGATION

Oncomutations as biomarkers of cancer risk

(2010) Barbara L. Parsons et al.   ENVIRONMENTAL AND MOLECULAR MUTAGENESIS

Linking environmental carcinogen exposure to TP53 mutations in human tumours using the human TP53 knock-in (Hupki) mouse model

(2010) Jill E. Kucab et al.   FEBS Journal

Gene expression changes induced by the human carcinogen aristolochic acid I in renal and hepatic tissue of mice

(2010) Volker M. Arlt et al.   INTERNATIONAL JOURNAL OF CANCER

Molecular Characterization of Preneoplastic Lesions Provides Insight on the Development of Renal Tumors

(2009) Kerstin Stemmer et al.   AMERICAN JOURNAL OF PATHOLOGY

TP53mutation signature supports involvement of aristolochic acid in the aetiology of endemic nephropathy-associated tumours

(2008) Tatiana Nedelko et al.   INTERNATIONAL JOURNAL OF CANCER

Aristolochic acid nephropathy: A worldwide problem

(2008) Frédéric D. Debelle et al.   KIDNEY INTERNATIONAL

A review of human carcinogens—Part A: pharmaceuticals

(2008) Yann Grosse et al.   LANCET ONCOLOGY

Simulated solar light‐inducedp53mutagenesis in SKH‐1 mouse skin: A dose–response assessment

(2008) Tracie L. Verkler et al.   MOLECULAR CARCINOGENESIS

Gene expression profiles modulated by the human carcinogen aristolochic acid I in human cancer cells and their dependence on TP53

(2008) Maria L. Simões et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Metabolic activation of carcinogenic aristolochic acid, a risk factor for Balkan endemic nephropathy

(2007) Marie Stiborová et al.   MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH